Literature DB >> 11312261

Positive and negative regulation of myogenic differentiation of C2C12 cells by isoforms of the multiple homeodomain zinc finger transcription factor ATBF1.

F B Berry1, Y Miura, K Mihara, P Kaspar, N Sakata, T Hashimoto-Tamaoki, T Tamaoki.   

Abstract

The ATBF1 gene encodes two protein isoforms, the 404-kDa ATBF1-A, possessing four homeodomains and 23 zinc fingers, and the 306-kDa ATBF1-B, lacking a 920-amino acid N-terminal region of ATBF1-A which contains 5 zinc fingers. In vitro, ATBF1-A was expressed in proliferating C2C12 myoblasts, but its expression levels decreased upon induction of myogenic differentiation in low serum medium. Forced expression of ATBF1-A in C2C12 cells resulted in repression of MyoD and myogenin expression and elevation of Id3 and cyclin D1 expression, leading to inhibition of myogenic differentiation in low serum. In contrast, transfection of C2C12 cells with the ATBF1-B isoform led to an acceleration of myogenic differentiation, as indicated by an earlier onset of myosin heavy chain expression and formation of a higher percentage of multinucleated myotubes. The fourth homeodomain of ATBF1-A bound to an AT-rich element adjacent to the E1 E-box of the muscle regulatory factor 4 promoter mediating transcriptional repression. The ATBF1-A-specific N-terminal region possesses general transcription repressor activity. These results suggest that ATBF1-A plays a role in the maintenance of the undifferentiated myoblast state, and its down-regulation is a prerequisite to initiate terminal differentiation of C2C12 cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11312261     DOI: 10.1074/jbc.M010378200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

1.  Heterozygous deletion of Atbf1 by the Cre-loxP system in mice causes preweaning mortality.

Authors:  Xiaodong Sun; Xiaoying Fu; Jie Li; Changsheng Xing; David W Martin; Helen Heju Zhang; Zhengjia Chen; Jin-Tang Dong
Journal:  Genesis       Date:  2012-06-21       Impact factor: 2.487

Review 2.  Emerging directions in the genetics of atrial fibrillation.

Authors:  Nathan R Tucker; Patrick T Ellinor
Journal:  Circ Res       Date:  2014-04-25       Impact factor: 17.367

Review 3.  The Role of Pharmacogenetics in Atrial Fibrillation Therapeutics: Is Personalized Therapy in Sight?

Authors:  Dawood Darbar
Journal:  J Cardiovasc Pharmacol       Date:  2016-01       Impact factor: 3.105

Review 4.  Genotype influence in responses to therapy for atrial fibrillation.

Authors:  Henry Huang; Dawood Darbar
Journal:  Expert Rev Cardiovasc Ther       Date:  2016-07-15

Review 5.  Interplay between cardiac transcription factors and non-coding RNAs in predisposing to atrial fibrillation.

Authors:  Alexander T Mikhailov; Mario Torrado
Journal:  J Mol Med (Berl)       Date:  2018-05-12       Impact factor: 4.599

6.  SUMOylation of the transcription factor ZFHX3 at Lys-2806 requires SAE1, UBC9, and PIAS2 and enhances its stability and function in cell proliferation.

Authors:  Rui Wu; Jiali Fang; Mingcheng Liu; Jun A; Jinming Liu; Wenxuan Chen; Juan Li; Gui Ma; Zhiqian Zhang; Baotong Zhang; Liya Fu; Jin-Tang Dong
Journal:  J Biol Chem       Date:  2020-04-05       Impact factor: 5.157

Review 7.  New advances in the genetic basis of atrial fibrillation.

Authors:  Saagar Mahida; Patrick T Ellinor
Journal:  J Cardiovasc Electrophysiol       Date:  2012-10-15

8.  Profiling of Hodgkin's lymphoma cell line L1236 and germinal center B cells: identification of Hodgkin's lymphoma-specific genes.

Authors:  Ines Schwering; Andreas Bräuninger; Verena Distler; Julia Jesdinsky; Volker Diehl; Martin-Leo Hansmann; Klaus Rajewsky; Ralf Küppers
Journal:  Mol Med       Date:  2003 Mar-Apr       Impact factor: 6.354

9.  Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry.

Authors:  Emelia J Benjamin; Kenneth M Rice; Dan E Arking; Arne Pfeufer; Charlotte van Noord; Albert V Smith; Renate B Schnabel; Joshua C Bis; Eric Boerwinkle; Moritz F Sinner; Abbas Dehghan; Steven A Lubitz; Ralph B D'Agostino; Thomas Lumley; Georg B Ehret; Jan Heeringa; Thor Aspelund; Christopher Newton-Cheh; Martin G Larson; Kristin D Marciante; Elsayed Z Soliman; Fernando Rivadeneira; Thomas J Wang; Gudny Eiríksdottir; Daniel Levy; Bruce M Psaty; Man Li; Alanna M Chamberlain; Albert Hofman; Ramachandran S Vasan; Tamara B Harris; Jerome I Rotter; W H Linda Kao; Sunil K Agarwal; Bruno H Ch Stricker; Ke Wang; Lenore J Launer; Nicholas L Smith; Aravinda Chakravarti; André G Uitterlinden; Philip A Wolf; Nona Sotoodehnia; Anna Köttgen; Cornelia M van Duijn; Thomas Meitinger; Martina Mueller; Siegfried Perz; Gerhard Steinbeck; H-Erich Wichmann; Kathryn L Lunetta; Susan R Heckbert; Vilmundur Gudnason; Alvaro Alonso; Stefan Kääb; Patrick T Ellinor; Jacqueline C M Witteman
Journal:  Nat Genet       Date:  2009-07-13       Impact factor: 38.330

Review 10.  Genetic mechanisms of atrial fibrillation: impact on response to treatment.

Authors:  Dawood Darbar; Dan M Roden
Journal:  Nat Rev Cardiol       Date:  2013-04-16       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.